Overview
Arteriovenous malformations (AVMs) are abnormal, tangled connections between arteries and veins that bypass the capillary bed. This direct shunting of blood leads to high-flow circulation through fragile vessels, increasing the risk of vessel rupture and intracranial hemorrhage. AVMs can occur anywhere in the body, but central nervous system involvement—particularly within the brain and spinal cord—is most clinically significant due to potential neurological consequences.
Etiology and Pathophysiology
The exact cause of AVMs remains incompletely understood, but most evidence suggests they are congenital vascular malformations, meaning individuals are born with them. They are believed to arise during early embryonic development when the vascular system is forming, resulting in failure of normal capillary network differentiation.
Although primarily congenital, sporadic genetic mutations affecting vascular development pathways have been implicated, and rare familial forms exist, such as those associated with hereditary hemorrhagic telangiectasia (HHT). AVMs typically do not grow progressively like tumors, but their hemodynamic stress can lead to structural vessel weakness over time.
Clinical Presentation and Symptoms
Many AVMs remain asymptomatic and are detected incidentally on imaging. When symptomatic, manifestations depend on lesion size and location.
Intracranial AVMs
Symptoms may include:
Headaches, sometimes migraine-like
Seizures, a common presenting symptom
Focal neurological deficits, such as weakness, numbness, or speech disturbances
Intracerebral hemorrhage, resulting from rupture and often presenting with sudden severe headache (“worst headache of life”), altered mental status, or loss of consciousness
Vision changes, depending on vascular territory affected
Pulsatile tinnitus, if vascular flow impacts auditory pathways
Spinal AVMs
Back pain
Progressive weakness or sensory deficits
Bowel or bladder dysfunction
Peripheral AVMs
Pain, swelling, or a palpable pulsatile mass
Skin discoloration or ulcers due to poor perfusion
Diagnosis
Diagnosis is typically established through imaging modalities:
MRI/MRA – evaluates lesion location and surrounding brain tissue
CT/CTA – often used in acute hemorrhage
Digital Subtraction Angiography (DSA) – gold standard for detailed vascular mapping and treatment planning
Treatment
Management depends on AVM size, location, patient symptoms, and hemorrhage risk.
1. Microsurgical Resection
Considered curative when complete removal is possible
Preferred for accessible AVMs and in patients with prior hemorrhage
2. Endovascular Embolization
Minimally invasive technique where embolic agents are injected to reduce blood flow
Often used as adjunct therapy before surgery or stereotactic radiosurgery
3. Stereotactic Radiosurgery (e.g., Gamma Knife)
Focused radiation to induce gradual vessel occlusion
Beneficial for smaller AVMs or those in deep or eloquent brain regions
Obliteration typically occurs over months to years, leaving a risk of hemorrhage during latency
4. Observation
Appropriate for small, asymptomatic AVMs in low-risk locations or when treatment risk outweighs expected benefit
Prognosis
Prognosis varies largely by lesion characteristics and treatment approach:
Annual hemorrhage risk for untreated AVMs is approximately 2–4%, with increased risk after an initial bleed.
Hemorrhagic presentation increases risk of subsequent bleeding and worse neurological outcomes.
Successful treatment significantly reduces hemorrhage risk, though complications such as post-treatment deficits or seizures may persist depending on the lesion site.
Age and Risk Factors
AVMs are generally present at birth, but they are most commonly diagnosed between ages 10 and 40. This is because symptoms—particularly seizures or hemorrhage—tend to arise in young adulthood. AVMs are not strongly associated with sex or ethnicity, although individuals with genetic vascular disorders such as HHT have an increased risk.
Children and adolescents may be more vulnerable to long-term complications due to cumulative lifetime hemorrhage risk, while older adults may present after incidental detection or acute hemorrhage.
Key Points
AVMs are congenital vascular malformations characterized by abnormal arterial-venous shunting.
Clinical manifestations range from asymptomatic to life-threatening hemorrhage.
Microsurgery, embolization, and radiosurgery are mainstay treatment modalities.
Diagnosis most commonly occurs in young adults, though AVMs are present from birth.
Prognosis improves significantly with appropriate management, but risk of hemorrhage remains a major concern.
